279 related articles for article (PubMed ID: 30338719)
21. Solid lipid nanoparticles as carriers for oral delivery of hydroxysafflor yellow A.
Zhao B; Gu S; Du Y; Shen M; Liu X; Shen Y
Int J Pharm; 2018 Jan; 535(1-2):164-171. PubMed ID: 29107614
[TBL] [Abstract][Full Text] [Related]
22. Roxadustat promotes angiogenesis through HIF-1α/VEGF/VEGFR2 signaling and accelerates cutaneous wound healing in diabetic rats.
Zhu Y; Wang Y; Jia Y; Xu J; Chai Y
Wound Repair Regen; 2019 Jul; 27(4):324-334. PubMed ID: 30817065
[TBL] [Abstract][Full Text] [Related]
23. Nucleolin mediated pro-angiogenic role of Hydroxysafflor Yellow A in ischaemic cardiac dysfunction: Post-transcriptional regulation of VEGF-A and MMP-9.
Zou J; Wang N; Liu M; Bai Y; Wang H; Liu K; Zhang H; Xiao X; Wang K
J Cell Mol Med; 2018 May; 22(5):2692-2705. PubMed ID: 29512890
[TBL] [Abstract][Full Text] [Related]
24. Hydroxysafflor Yellow A Promotes Angiogenesis via the Angiopoietin 1/ Tie-2 Signaling Pathway.
Chen T; Chen N; Pang N; Xiao L; Li Y; Li R; Luo M; Deng X; Ren M; Wu J; Wang L
J Vasc Res; 2016; 53(5-6):245-254. PubMed ID: 27894114
[TBL] [Abstract][Full Text] [Related]
25. Protective Effect of Hydroxysafflor Yellow A on Nephropathy by Attenuating Oxidative Stress and Inhibiting Apoptosis in Induced Type 2 Diabetes in Rat.
Lee M; Zhao H; Liu X; Liu D; Chen J; Li Z; Chu S; Kou X; Liao S; Deng Y; Li H; Xie W
Oxid Med Cell Longev; 2020; 2020():7805393. PubMed ID: 32256962
[TBL] [Abstract][Full Text] [Related]
26. Bioactive antibacterial silica-based nanocomposites hydrogel scaffolds with high angiogenesis for promoting diabetic wound healing and skin repair.
Li Y; Xu T; Tu Z; Dai W; Xue Y; Tang C; Gao W; Mao C; Lei B; Lin C
Theranostics; 2020; 10(11):4929-4943. PubMed ID: 32308759
[TBL] [Abstract][Full Text] [Related]
27. VH298-loaded extracellular vesicles released from gelatin methacryloyl hydrogel facilitate diabetic wound healing by HIF-1α-mediated enhancement of angiogenesis.
Wang Y; Cao Z; Wei Q; Ma K; Hu W; Huang Q; Su J; Li H; Zhang C; Fu X
Acta Biomater; 2022 Jul; 147():342-355. PubMed ID: 35580827
[TBL] [Abstract][Full Text] [Related]
28. Hypoxia-induced angiogenesis is increased by the controlled release of deferoxiamine from gelatin hydrogels.
Saito T; Tabata Y
Acta Biomater; 2014 Aug; 10(8):3641-9. PubMed ID: 24769115
[TBL] [Abstract][Full Text] [Related]
29. A novel oral preparation of hydroxysafflor yellow A base on a chitosan complex: a strategy to enhance the oral bioavailability.
Ma GN; Yu FL; Wang S; Li ZP; Xie XY; Mei XG
AAPS PharmSciTech; 2015 Jun; 16(3):675-82. PubMed ID: 25511808
[TBL] [Abstract][Full Text] [Related]
30. Injectable Desferrioxamine-Laden Silk Nanofiber Hydrogels for Accelerating Diabetic Wound Healing.
Ding Z; Zhang Y; Guo P; Duan T; Cheng W; Guo Y; Zheng X; Lu G; Lu Q; Kaplan DL
ACS Biomater Sci Eng; 2021 Mar; 7(3):1147-1158. PubMed ID: 33522800
[TBL] [Abstract][Full Text] [Related]
31. Topical naltrexone accelerates full-thickness wound closure in type 1 diabetic rats by stimulating angiogenesis.
McLaughlin PJ; Immonen JA; Zagon IS
Exp Biol Med (Maywood); 2013 Jul; 238(7):733-43. PubMed ID: 23788174
[TBL] [Abstract][Full Text] [Related]
32. Promoting tissue repair using deferoxamine nanoparticles loaded biomimetic gelatin/HA composite hydrogel.
Li J; Lu X; Weng M; Wang Y; Tang J; Xu Q; Zhang L; Bai J
Biomed Mater; 2024 May; 19(4):. PubMed ID: 38697149
[TBL] [Abstract][Full Text] [Related]
33. Topical bilirubin-deferoxamine hastens excisional wound healing by modulating inflammation, oxidative stress, angiogenesis, and collagen deposition in diabetic rats.
Aneesha VA; Qayoom A; Anagha S; Almas SA; Naresh VK; Kumawat S; Singh WR; Sadam A; Dinesh M; Shyamkumar TS; Sahoo M; Lingaraju MC; Singh TU; Kumar D
J Tissue Viability; 2022 Aug; 31(3):474-484. PubMed ID: 35595596
[TBL] [Abstract][Full Text] [Related]
34. Deferoxamine-Loaded Injectable Chitosan-Grafted Chlorogenic Acid/Oxidized Hyaluronic Acid Hybrid Hydrogel with Antibacterial, Anti-inflammatory, and Angiogenesis-Promoting Properties for Diabetic Wound Repair.
Zhong H; Fang Y; Luo M; Wang L; Huang J; Dai G; Liu K; Wu J; Du J
ACS Appl Mater Interfaces; 2024 Jun; 16(22):28209-28221. PubMed ID: 38778020
[TBL] [Abstract][Full Text] [Related]
35. Hydroxysafflor Yellow a Promotes Angiogenesis in Rat Brain Microvascular Endothelial Cells Injured by Oxygen-glucose Deprivation/reoxygenation(OGD/R) through SIRT1-HIF-1α-VEGFA Signaling Pathway.
Ruan J; Wang L; Dai J; Li J; Wang N; Seto S
Curr Neurovasc Res; 2021; 18(4):415-426. PubMed ID: 34751117
[TBL] [Abstract][Full Text] [Related]
36. The angiogenic response to PLL-g-PEG-mediated HIF-1α plasmid DNA delivery in healthy and diabetic rats.
Thiersch M; Rimann M; Panagiotopoulou V; Öztürk E; Biedermann T; Textor M; Lühmann TC; Hall H
Biomaterials; 2013 May; 34(16):4173-4182. PubMed ID: 23465832
[TBL] [Abstract][Full Text] [Related]
37. The subchronic toxicity of hydroxysafflor yellow A of 90 days repeatedly intraperitoneal injections in rats.
Liu Z; Li C; Li M; Li D; Liu K
Toxicology; 2004 Oct; 203(1-3):139-43. PubMed ID: 15363589
[TBL] [Abstract][Full Text] [Related]
38. Exosomes Derived from Human Bone Marrow Mesenchymal Stem Cells Stimulated by Deferoxamine Accelerate Cutaneous Wound Healing by Promoting Angiogenesis.
Ding J; Wang X; Chen B; Zhang J; Xu J
Biomed Res Int; 2019; 2019():9742765. PubMed ID: 31192260
[TBL] [Abstract][Full Text] [Related]
39. An antibacterial and proangiogenic double-layer drug-loaded microneedle patch for accelerating diabetic wound healing.
Gao S; Zhang W; Zhai X; Zhao X; Wang J; Weng J; Li J; Chen X
Biomater Sci; 2023 Jan; 11(2):533-541. PubMed ID: 36472206
[TBL] [Abstract][Full Text] [Related]
40. Enhancing effect of Labrafac Lipophile WL 1349 on oral bioavailability of hydroxysafflor yellow A in rats.
Wang S; Sun M; Ping Q
Int J Pharm; 2008 Jun; 358(1-2):198-204. PubMed ID: 18417306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
